Autopsy report · NCT00937053

Maintaining a Higher Level of Haemoglobin: Effect on the White Cells After Bone Marrow Transplantation in Children.

“3 unexpected Serious Adverse Events (veno-occlusive disease (VOD))”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 6 years before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

St. Justine's Hospital

Sponsor type

University, hospital or other

Conditions

Neutropenia

Interventions

Transfusion level 120 g/dL; Transfusion level 70 g/dL; Platelet transfusion

Participants

6

Sites

5

Countries

Canada

Trials that died the same way

• Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures
  “unexpected serious adverse event” (58% match in meaning)
• Development of Cocktail for Measuring the Activity of Important Cytochrome P450 Enzymes
  “Unexpected non-serious adverse events” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.